Rosemary Harrup

2.4k total citations
50 papers, 470 citations indexed

About

Rosemary Harrup is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Rosemary Harrup has authored 50 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 17 papers in Public Health, Environmental and Occupational Health and 10 papers in Hematology. Recurrent topics in Rosemary Harrup's work include Chronic Lymphocytic Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (9 papers) and Glioma Diagnosis and Treatment (8 papers). Rosemary Harrup is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (9 papers) and Glioma Diagnosis and Treatment (8 papers). Rosemary Harrup collaborates with scholars based in Australia, United States and New Zealand. Rosemary Harrup's co-authors include Michael Osborn, Rachel Conyers, Helen Bibby, Antoinette Anazodo, Michael Coory, Victoria White, Gemma Skaczkowski, Lisa Orme, Marianne Phillips and Ross Pinkerton and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Rosemary Harrup

45 papers receiving 460 citations

Peers

Rosemary Harrup
Ardine Reedijk Netherlands
Michael Osborn Australia
Starlene Loader United States
Marcia Leonard United States
Nicholas D. Yeager United States
Pinki Prasad United States
Philip D. Poorvu United States
Rosemary Harrup
Citations per year, relative to Rosemary Harrup Rosemary Harrup (= 1×) peers Eugenia Piliotis

Countries citing papers authored by Rosemary Harrup

Since Specialization
Citations

This map shows the geographic impact of Rosemary Harrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Harrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Harrup more than expected).

Fields of papers citing papers by Rosemary Harrup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Harrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Harrup. The network helps show where Rosemary Harrup may publish in the future.

Co-authorship network of co-authors of Rosemary Harrup

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Harrup. A scholar is included among the top collaborators of Rosemary Harrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Harrup. Rosemary Harrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Oliver, Matteo S. Carlino, Craig Underhill, et al.. (2024). 713MO Nivolumab and ipilimumab combination treatment in advanced gynaecological clear cell cancers: Results from the phase II MoST-CIRCUIT trial. Annals of Oncology. 35. S546–S547. 5 indexed citations
3.
Klein, Oliver, Matteo S. Carlino, Michelle Brown, et al.. (2024). 282P Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancer. Annals of Oncology. 35. S119–S119. 2 indexed citations
4.
Klein, Oliver, Bo Gao, Henry Chan, et al.. (2024). 998MO Nivolumab and ipilimumab combination treatment in advanced dMMR/MSI-H noncolorectal cancers: Results from the phase II MoST-CIRCUIT study. Annals of Oncology. 35. S679–S680. 1 indexed citations
6.
Kater, Arnon P., Rosemary Harrup, Thomas J. Kipps, et al.. (2023). MURANO: Final 7 year follow up and retreatment analysis in venetoclax‐rituximab (VenR)‐treated patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL). Hematological Oncology. 41(S2). 239–242. 8 indexed citations
7.
Gan, Hui, Bryan W. Day, Rosemary Harrup, et al.. (2023). Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future. Current Oncology Reports. 25(6). 589–598. 3 indexed citations
8.
Yang, Yi, Fiona Bruinsma, Anna K. Nowak, et al.. (2022). Physical activity and glioma: a case–control study with follow-up for survival. Cancer Causes & Control. 33(5). 749–757. 1 indexed citations
10.
Kong, Benjamin Y., Hao‐Wen Sim, Elizabeth H Barnes, et al.. (2022). Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma. BMJ Open. 12(9). e058107–e058107. 4 indexed citations
11.
Gately, Lucy, Katharine J. Drummond, Mark Rosenthal, et al.. (2022). Beyond standard data collection – the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry). BMC Cancer. 22(1). 604–604. 4 indexed citations
12.
Harrup, Rosemary, Victoria White, Michael Coory, et al.. (2020). Treatment and Outcomes for Central Nervous System Tumors in Australian Adolescents and Young Adults: A Population-Based National Study. Journal of Adolescent and Young Adult Oncology. 10(2). 202–208. 3 indexed citations
13.
Kirby, Emma, Alex Broom, Deme Karikios, Rosemary Harrup, & Zarnie Lwin. (2019). Exploring the impact and experience of fractional work in medicine: a qualitative study of medical oncologists in Australia. BMJ Open. 9(12). e032585–e032585. 5 indexed citations
14.
White, Victoria, Lisa Orme, Gemma Skaczkowski, et al.. (2019). Management of Sarcoma in Adolescents and Young Adults: An Australian Population-Based Study. Journal of Adolescent and Young Adult Oncology. 8(3). 272–280. 5 indexed citations
15.
Karapetis, Christos S., B. Stein, Bogda Koczwara, et al.. (2018). Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying. Internal Medicine Journal. 48(7). 774–779. 23 indexed citations
16.
Wong, WK, Emma Kirby, Alex Broom, et al.. (2018). A mixed methods analysis of experiences and expectations among early‐career medical oncologists in Australia. Asia-Pacific Journal of Clinical Oncology. 14(5). e521–e527. 3 indexed citations
17.
Lwin, Zarnie, Alex Broom, David Sibbritt, et al.. (2018). The Australian Medical Oncologist Workforce Survey: The profile and challenges of medical oncology. Seminars in Oncology. 45(5-6). 284–290. 8 indexed citations
18.
White, Victoria, Gemma Skaczkowski, Antoinette Anazodo, et al.. (2018). Clinical trial participation by adolescents and young adults with cancer: A continued cause for concern?. Seminars in Oncology. 45(5-6). 275–283. 5 indexed citations
19.
White, Victoria, Gemma Skaczkowski, Kate Thompson, et al.. (2018). Experiences of Care of Adolescents and Young Adults with Cancer in Australia. Journal of Adolescent and Young Adult Oncology. 7(3). 315–325. 23 indexed citations
20.
Broom, Alex, WK Wong, Emma Kirby, et al.. (2016). A Qualitative Study of Medical Oncologists’ Experiences of Their Profession and Workforce Sustainability. PLoS ONE. 11(11). e0166302–e0166302. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026